Loading…
2021 DORIS definition of remission in SLE: final recommendations from an international task force
van Vollenhoven, Ronald F, Bertsias, George, Doria, Andrea, Isenberg, David, Morand, Eric, Petri, Michelle A, Pons-Estel, Bernardo A, Rahman, Anisur, Ugarte-Gil, Manuel Francisco, Voskuyl, Alexandre, Arnaud, Laurent, Bruce, Ian N, Cervera, Ricard, Costedoat-Chalumeau, Nathalie, Gordon, Caroline, Houssiau, Frédéric A, Mosca, Marta, Schneider, Matthias, Ward, Michael M, Alarcon, Graciela, Aringer, Martin, Askanase, Anca D, Bae, Sang-Cheol, Bootsma, Hendrika, Boumpas, Dimitrios T, Brunner, Hermine, Clarke, Ann Elaine, Coney, Cindy, Czirják, László, Dörner, Thomas, Faria, Raquel, Fischer, Rebecca, Fritsch-Stork, Ruth, Inanc, Murat, Jacobsen, Søren, Jayne, David, Kuhn, Annegret, van Leeuw, Bernadette, Limper, Maarten, Mariette, Xavier, Navarra, Sandra, Nikpour, Mandana, Olesinska, Marzena Helena, Pons-Estel, Guillermo, Romero-Diaz, Juanita, Rubio, Blanca, Schoenfeld, Yehuda, Bonfá, Eloisa, Smolen, Josef, Teng, Y K Onno, Tincani, Angela, Tsang-A-Sjoe, Michel, Vasconcelos, Carlos, Voss, Anne, Werth, Victoria P, Zakharhova, Elena, Aranow, Cynthia
Published in Lupus science & medicine (01.11.2021)
Published in Lupus science & medicine (01.11.2021)
Get full text
Journal Article
Loading…
Loading…
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies
Ugarte-Gil, Manuel Francisco, Mak, Anselm, Leong, Joanna, Dharmadhikari, Bhushan, Kow, Nien Yee, Reátegui-Sokolova, Cristina, Elera-Fitzcarrald, Claudia, Aranow, Cinthia, Arnaud, Laurent, Askanase, Anca D, Bae, Sang-Cheol, Bernatsky, Sasha, Bruce, Ian N, Buyon, Jill, Costedoat-Chalumeau, Nathalie, Dooley, Mary Ann, Fortin, Paul R, Ginzler, Ellen M, Gladman, Dafna D, Hanly, John, Inanc, Murat, Isenberg, David, Jacobsen, Soren, James, Judith A, Jönsen, Andreas, Kalunian, Kenneth, Kamen, Diane L, Lim, Sung Sam, Morand, Eric, Mosca, Marta, Peschken, Christine, Pons-Estel, Bernardo A, Rahman, Anisur, Ramsey-Goldman, Rosalind, Reynolds, John, Romero-Diaz, Juanita, Ruiz-Irastorza, Guillermo, Sánchez-Guerrero, Jorge, Svenungsson, Elisabet, Urowitz, Murray, Vinet, Evelyne, van Vollenhoven, Ronald F, Voskuyl, Alexandre, Wallace, Daniel J, Petri, Michelle A, Manzi, Susan, Clarke, Ann Elaine, Cheung, Mike, Farewell, Vernon, Alarcon, Graciela S.
Published in Lupus science & medicine (20.12.2021)
Published in Lupus science & medicine (20.12.2021)
Get full text
Journal Article
Loading…
Living with systemic lupus erythematosus in 2020: a European patient survey
Cornet, Alain, Andersen, Jeanette, Myllys, Kirsi, Edwards, Angela, Arnaud, Laurent
Published in Lupus science & medicine (13.04.2021)
Published in Lupus science & medicine (13.04.2021)
Get full text
Journal Article
Loading…
Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice
Fortner, Karen A, Blanco, Luz P, Buskiewicz, Iwona, Huang, Nick, Gibson, Pamela C, Cook, Deborah L, Pedersen, Hege L, Yuen, Peter S T, Murphy, Michael P, Perl, Andras, Kaplan, Mariana J, Budd, Ralph C
Published in Lupus science & medicine (16.04.2020)
Published in Lupus science & medicine (16.04.2020)
Get full text
Journal Article
Loading…
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
Tamirou, Farah, Lauwerys, Bernard R, Dall'Era, Maria, Mackay, Meggan, Rovin, Brad, Cervera, Ricard, Houssiau, Frédéric A
Published in Lupus science & medicine (01.11.2015)
Published in Lupus science & medicine (01.11.2015)
Get full text
Journal Article
Loading…
Prediction of prognosis and renal outcome in lupus nephritis
Parodis, Ioannis, Tamirou, Farah, Houssiau, Frédéric A
Published in Lupus science & medicine (01.01.2020)
Published in Lupus science & medicine (01.01.2020)
Get full text
Journal Article
Loading…
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Tummala, Raj, Abreu, Gabriel, Pineda, Lilia, Michaels, M Alex, Kalyani, Rubana N, Furie, Richard A, Morand, Eric F
Published in Lupus science & medicine (17.02.2021)
Published in Lupus science & medicine (17.02.2021)
Get full text
Journal Article
Loading…
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
van Vollenhoven, Ronald, Askanase, Anca D, Bomback, Andrew S, Bruce, Ian N, Carroll, Angela, Dall'Era, Maria, Daniels, Mark, Levy, Roger A, Schwarting, Andreas, Quasny, Holly A, Urowitz, Murray B, Zhao, Ming-Hui, Furie, Richard
Published in Lupus science & medicine (01.03.2022)
Published in Lupus science & medicine (01.03.2022)
Get full text
Journal Article
Loading…
Loading…
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
Riggs, Jeffrey M, Hanna, Richard N, Rajan, Bhargavi, Zerrouki, Kamelia, Karnell, Jodi L, Sagar, Divya, Vainshtein, Inna, Farmer, Erika, Rosenthal, Kimberly, Morehouse, Chris, de los Reyes, Melissa, Schifferli, Kevin, Liang, Meina, Sanjuan, Miguel A, Sims, Gary P, Kolbeck, Roland
Published in Lupus science & medicine (01.01.2018)
Published in Lupus science & medicine (01.01.2018)
Get full text
Journal Article
Loading…
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort
Al Sawah, Sarah, Zhang, Xiang, Zhu, Baojin, Magder, Laurence S, Foster, Shonda A, Iikuni, Noriko, Petri, Michelle
Published in Lupus science & medicine (01.03.2015)
Published in Lupus science & medicine (01.03.2015)
Get full text
Journal Article
Loading…
Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
Northcott, Melissa, Jones, Sarah, Koelmeyer, Rachel, Bonin, Julie, Vincent, Fabien, Kandane-Rathnayake, Rangi, Hoi, Alberta, Morand, Eric
Published in Lupus science & medicine (01.02.2022)
Published in Lupus science & medicine (01.02.2022)
Get full text
Journal Article
Loading…
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE
Kamen, Diane L, Wallace, Caroline, Li, Zihai, Wyatt, Megan, Paulos, Crystal, Wei, Chungwen, Wang, Hongjun, Wolf, Bethany J, Nietert, Paul J, Gilkeson, Gary
Published in Lupus science & medicine (01.07.2022)
Published in Lupus science & medicine (01.07.2022)
Get full text
Journal Article
Loading…
Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years
Ajeganova, Sofia, Hafström, Ingiäld, Frostegård, Johan
Published in Lupus science & medicine (05.02.2021)
Published in Lupus science & medicine (05.02.2021)
Get full text
Journal Article
Loading…
Phenotypical changes and clinical significance of CD4+/CD8+ T cells in SLE
Yuan, Shiwen, Zeng, Yanting, Li, Jiawei, Wang, Cuicui, Li, Weinian, He, Zhixiang, Ye, Jinghua, Li, Fangfei, Chen, Yi, Lin, Xiaojun, Yu, Na, Cai, Xiaoyan
Published in Lupus science & medicine (01.06.2022)
Published in Lupus science & medicine (01.06.2022)
Get full text
Journal Article
Loading…
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways
Dörner, Thomas, Tanaka, Yoshiya, Petri, Michelle A, Smolen, Josef S, Wallace, Daniel J, Dow, Ernst R, Higgs, Richard E, Rocha, Guilherme, Crowe, Brenda, Benschop, Robert J, Byers, Nicole L, Silk, Maria E, de Bono, Stephanie, Fantini, Damiano, Hoffman, Robert W
Published in Lupus Science & Medicine (01.10.2020)
Published in Lupus Science & Medicine (01.10.2020)
Get full text
Journal Article
Loading…
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial
Jayne, David, Rovin, Brad, Mysler, Eduardo, Furie, Richard, Houssiau, Frédéric, Trasieva, Teodora, Knagenhjelm, Jacob, Schwetje, Erik, Tang, Weifeng, Tummala, Raj, Lindholm, Catharina
Published in Lupus science & medicine (01.08.2023)
Published in Lupus science & medicine (01.08.2023)
Get full text
Journal Article
Loading…
Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study
Jin, Hui-Zhi, Li, Yu-jing, Wang, Xin, Li, Zhijun, Ma, Bin, Niu, Lin, Wang, Peng, Pan, Hai-feng, Li, Si-dong, Bao, Wei, Wang, Guosheng, Li, Xiao-mei, Chen, Zhu
Published in Lupus science & medicine (24.11.2023)
Published in Lupus science & medicine (24.11.2023)
Get full text
Journal Article
Loading…
Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway
Chen, Xiao-cui, Wu, Dan, Wu, Hong-luan, Li, Hui-yuan, Yang, Chen, Su, Hong-yong, Liu, Ze-jian, Huang, Xiao-rong, Lu, Xing, Huang, Li-feng, Zhu, Shao-ping, Pan, Qing-jun, An, Ning, Liu, Hua-feng
Published in Lupus science & medicine (01.04.2022)
Published in Lupus science & medicine (01.04.2022)
Get full text
Journal Article